Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Cardiotonic   Dopamine hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Abbodop Denmark, Finland, Sweden
Cardiopal Colombia
Dopadic Iran
Dopadren Turkey
Dopamin Austria, Germany, Saudi Arabia, Switzerland
Dopamina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Peru, Spain, Venezuela
Dopamine Canada, France, Luxembourg, Morocco, Netherlands, United States of America
Dopaminum Poland
Dopmin Denmark, Finland, Malaysia, Turkey
Dynatra Belgium, Luxembourg, Netherlands
Giludop Denmark, Greece, Sweden
Intropin Egypt
Miocina Mexico
Myofast Colombia
Myotil Texte introuvable (616, )
Paldopa Peru
Revivan Mexico
Zetarina Mexico
Stability in solutions   Injection   Stability in solutions : Dopamine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,8 mg/ml 23-25°C Light
48 Hour
732
Level of evidence D
Glass Glucose 5% 0,8 mg/ml 5°C Protect from light
7 Day
732
Level of evidence D
Glass Glucose 5% 1 mg/ml 25°C Light
36 Hour
1249
Level of evidence B
Glass Ringer’s lactate solution 0,8 mg/ml 23-25°C Light
48 Hour
732
Level of evidence D
Polyvinyl chloride Glucose 5% 0,8 mg/ml 25°C Light
24 Hour
732
Level of evidence D
Polyvinyl chloride Glucose 5% 3,2 mg/ml 5°C Protect from light
14 Day
197
Level of evidence D
Polyvinyl chloride Glucose 5% 6,4 mg/ml 23°C Light
24 Hour
192
Level of evidence B
Polypropylen Syringe NaCl 0,9% or Glucose 5% 10 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe NaCl 0,9% or Glucose 5% 2 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe NaCl 0,9% or Glucose 5% 30 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Glucose 5% 0,5 mg/ml 25°C Protect from light
7 Day
1820
Level of evidence A
Polypropylen Syringe Glucose 5% 0,5 mg/ml 4°C Protect from light
120 Day
1820
Level of evidence A
Polypropylen Syringe Glucose 5% 4 mg/ml 23-25°C With or without light
48 Hour
206
Level of evidence C
Polypropylen Syringe Glucose 5% 4 mg/ml 25°C Light
24 Hour
196
Level of evidence D
Polypropylen Syringe Glucose 5% 4 mg/ml 4°C With or without light
48 Hour
206
Level of evidence C
Polypropylen Syringe Glucose 10% 10 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Glucose 10% 2 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Glucose 10% 30 mg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Not specified NaCl 0,9% or Glucose 5% 0,4 >> 1 mg/ml 25°C Light
24 Hour
1698
Level of evidence B
Not specified NaCl 0,9% or Glucose 5% 0,4 >> 3,2 mg/ml 25°C Not specified
48 Hour
3638
Manufacturer's stability data
Not specified Glucose 5% 0,4 >> 1 mg/ml 2-8°C Protect from light
14 Day
1698
Level of evidence B
  Mentions Légales